Phase IIa

Connecting you with the right people to speed your development.

At this stage, the right data will show regulators and investors that your new molecule is effective and ready to progress. Therefore, access to focused support is critical to generating relevant data.

In response to this need, we’ve developed an integrated and adaptive approach that supports your Phase IIa outcomes. By helping you swiftly find the right volunteers, and assistance with biostatistical and ePRO technologies, we work together to propel your product forward, providing support and passion along the way.

Patient Recruitment

Learn more about our patient recruitment and retention services.

Learn More

Parexel's Sy Pretorius on our Patient Innovation Center

Watch Now

Elevate Your Medical Writing Team To Success

View Now

Crafting a genomics strategy early is key for successful oncology drug development

View Now

A Pilot Study to Assess the Feasibility of Collecting and Transmitting Clinical Trial Data with Mobile Technologies

Read Now

Podcast: Drug Development Innovation Through Adaptive Trials

Read Now

We are always available for a conversation.

*